Scarica l'app Stockscreener
3.54
2.61%
0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.45
Aprire:
$3.5
Volume 24 ore:
759.91K
Relative Volume:
0.31
Capitalizzazione di mercato:
$380.40M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-1.2873
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
+8.26%
1M Prestazione:
+16.83%
6M Prestazione:
+27.80%
1 anno Prestazione:
-69.69%
Intervallo 1D:
$3.46
$3.545
Intervallo di 1 settimana:
$3.19
$3.595
Portata 52W:
$2.19
$13.35
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Nome
Rocket Pharmaceuticals Inc
Settore
Industria
Telefono
646-440-9100
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Confronta RCKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.515 | 373.37M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.99 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.50 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.69 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.95 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.41 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-08-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-30 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Downgrade | Goldman | Neutral → Sell |
| 2025-05-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Downgrade | Needham | Buy → Hold |
| 2025-05-27 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2024-12-30 | Iniziato | Wedbush | Outperform |
| 2024-12-18 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-04-02 | Iniziato | Goldman | Neutral |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Iniziato | Morgan Stanley | Overweight |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-01 | Iniziato | BTIG Research | Buy |
| 2022-07-08 | Iniziato | Raymond James | Outperform |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Iniziato | JP Morgan | Overweight |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2019-11-06 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-26 | Iniziato | Piper Jaffray | Overweight |
| 2019-04-23 | Iniziato | Robert W. Baird | Outperform |
| 2019-03-15 | Iniziato | BofA/Merrill | Buy |
| 2019-02-05 | Iniziato | Oppenheimer | Outperform |
| 2018-09-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryResistance Zone Identification & Free Fastest Return On Investment - Bollywood Helpline
Published on: 2025-12-24 06:58:20 - earlytimes.in
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economyQuarterly Earnings Review & Free Discover Massive Upside Stocks - Bollywood Helpline
Will Rocket Pharmaceuticals Inc. Equity Warrant stock remain a Wall Street favoriteWeekly Profit Analysis & Long Hold Capital Preservation Plans - Улправда
How buybacks impact Rocket Pharmaceuticals Inc. stock valueMarket Rally & Expert Approved Momentum Trade Ideas - Улправда
Will Rocket Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Weekly Recap & Daily Entry Point Alerts - Bölüm Sonu Canavarı
Published on: 2025-12-20 17:40:18 - Улправда
Rocket Pharmaceuticals (NASDAQ:RCKT) Raised to Hold at TD Cowen - MarketBeat
Published on: 2025-12-20 11:21:01 - Улправда
Is Rocket Pharmaceuticals Inc. Equity Warrant stock dividend yield sustainableJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - Улправда
Can Rocket Pharmaceuticals Inc. Equity Warrant stock sustain institutional interest2025 Breakouts & Breakdowns & Weekly Top Performers Watchlists - Улправда
Can Rocket Pharmaceuticals Inc. stock hit analyst price targetsMarket Risk Report & Daily Entry Point Alerts - Улправда
What margin trends mean for Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда
Published on: 2025-12-19 17:54:30 - DonanımHaber
Will Rocket Pharmaceuticals Inc. stock rally after Fed decisions2025 Retail Activity & Long-Term Growth Portfolio Plans - DonanımHaber
Will Rocket Pharmaceuticals Inc. Equity Warrant stock maintain dividend yieldJuly 2025 Levels & Safe Swing Trade Setups - DonanımHaber
Stop Loss: Will Rocket Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsWeekly Risk Report & Verified Short-Term Trading Plans - DonanımHaber
Rally Mode: What is the fair value of Rocket Pharmaceuticals Inc. stock nowJuly 2025 WrapUp & Low Drawdown Trading Techniques - ulpravda.ru
Why analysts remain bullish on Rocket Pharmaceuticals Inc. stockWeekly Trade Report & High Accuracy Trade Alerts - Улправда
Published on: 2025-12-18 21:01:52 - Улправда
Published on: 2025-12-18 16:59:15 - Улправда
Market Fear: Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentum2025 Market Overview & Intraday High Probability Alerts - Улправда
Published on: 2025-12-18 16:13:14 - Улправда
Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentumWeekly Trading Summary & AI Powered Market Entry Strategies - ulpravda.ru
Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders - Yahoo Finance
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Finviz
Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory - MSN
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Maverick Capital Ltd. Has $20.49 Million Stock Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Working capital per share of Rocket Pharmaceuticals, Inc. – SWB:9IP1 - TradingView — Track All Markets
Rocket Pharmaceuticals (NASDAQ:RCKT) Share Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
We're Keeping An Eye On Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Rate - Sahm
What analysts say about Rocket Pharmaceuticals Inc stockConsumer Goods Stocks & Small Entry Cost Investments - earlytimes.in
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - MSN
Forecast Cut: Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - moha.gov.vn
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correctionJobs Report & High Accuracy Trade Alerts - Newser
What Wall Street predicts for Rocket Pharmaceuticals Inc. Equity Warrant stock price - Newser
Rocket Pharmaceuticals heads to Lisbon for Cardio Genomics Meeting - Traders Union
Is Rocket Pharmaceuticals Inc. (9IP1) stock among top earnings playsWeekly Profit Report & Expert Approved Trade Ideas - Newser
Will Rocket Pharmaceuticals Inc. (9IP1) stock test record highs in 20252025 Big Picture & Growth Oriented Trade Recommendations - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant stock near bottom after declineWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Rocket Pharmaceuticals Inc. stock positioned well for digital economyPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earnings2025 Volatility Report & Free Expert Verified Stock Movement Alerts - Newser
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy on weaknessMarket Rally & Daily Stock Trend Watchlist - Newser
Published on: 2025-12-02 03:22:04 - Newser
Published on: 2025-12-02 19:13:04 - BỘ NỘI VỤ
Class Action Alert: Levi & Korsinsky Reminds Rocket (RCKT) Investors of August 11, 2025 Deadline - The National Law Review
Securities Class Action Lawsuit Filed Against Rocket Pharmaceutic - The National Law Review
Rocket Pharmaceuticals Inc (RCKTW) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Rocket Pharmaceuticals Inc Azioni (RCKT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Shah Gaurav | CEO |
Nov 18 '25 |
Sale |
2.98 |
6,276 |
18,721 |
778,296 |
| Militello John | See Remarks |
Nov 18 '25 |
Sale |
2.98 |
1,086 |
3,240 |
65,920 |
| Wilson Martin | General Counsel |
Nov 18 '25 |
Sale |
2.98 |
1,646 |
4,910 |
383,816 |
0.63%
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):